CCR9 (extracellular) Blocking Peptide (#BLP-CR029) is the original antigen used for immunization during Anti-CCR9 (extracellular) Antibody (#ACR-029) generation. The blocking peptide binds and ‘blocks’ Anti-CCR9 (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of human acute T cell leukemia (Jurkat) (lanes 1 and 3), human melanoma (MALME-3M) (lanes 2 and 4), human adenocarcinoma (HT-29) (lanes 5 and 7) and mouse T-cell lymphoma (TK-1) (lanes 6 and 8) cell line lysates:
- (C)DESTKLKSAVLTLK, corresponding to amino acid residues 205-218 of human CCR9 (Accession P51686).